nodes	percent_of_prediction	percent_of_DWPC	metapath
Simvastatin—UGT2B7—Epirubicin—sarcoma	0.115	0.149	CbGbCtD
Simvastatin—CYP2B6—Thiotepa—sarcoma	0.11	0.143	CbGbCtD
Simvastatin—UGT1A1—Etoposide—sarcoma	0.0773	0.1	CbGbCtD
Simvastatin—ABCC2—Vincristine—sarcoma	0.0513	0.0665	CbGbCtD
Simvastatin—ABCC2—Etoposide—sarcoma	0.047	0.061	CbGbCtD
Simvastatin—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.0343	0.0444	CbGbCtD
Simvastatin—CYP3A7—Vincristine—sarcoma	0.0343	0.0444	CbGbCtD
Simvastatin—CYP3A4—Thiotepa—sarcoma	0.0339	0.0439	CbGbCtD
Simvastatin—ABCC2—Doxorubicin—sarcoma	0.0321	0.0416	CbGbCtD
Simvastatin—ABCB1—Dactinomycin—sarcoma	0.0272	0.0352	CbGbCtD
Simvastatin—CYP3A5—Vincristine—sarcoma	0.0257	0.0333	CbGbCtD
Simvastatin—ABCB1—Mitoxantrone—sarcoma	0.0243	0.0315	CbGbCtD
Simvastatin—CYP3A5—Etoposide—sarcoma	0.0236	0.0305	CbGbCtD
Simvastatin—CYP2C8—Etoposide—sarcoma	0.0227	0.0294	CbGbCtD
Simvastatin—CYP2B6—Doxorubicin—sarcoma	0.0204	0.0264	CbGbCtD
Simvastatin—ABCB1—Vincristine—sarcoma	0.0167	0.0217	CbGbCtD
Simvastatin—ABCB1—Etoposide—sarcoma	0.0153	0.0199	CbGbCtD
Simvastatin—CYP3A4—Mitoxantrone—sarcoma	0.0146	0.0189	CbGbCtD
Simvastatin—ABCB1—Doxorubicin—sarcoma	0.0105	0.0136	CbGbCtD
Simvastatin—CYP3A4—Vincristine—sarcoma	0.01	0.013	CbGbCtD
Simvastatin—CYP2D6—Doxorubicin—sarcoma	0.00985	0.0128	CbGbCtD
Simvastatin—CYP3A4—Etoposide—sarcoma	0.00919	0.0119	CbGbCtD
Simvastatin—ITGB2—endothelium—sarcoma	0.00627	0.0937	CbGeAlD
Simvastatin—CYP3A4—Doxorubicin—sarcoma	0.00627	0.00812	CbGbCtD
Simvastatin—ITGB2—mammary gland—sarcoma	0.00505	0.0755	CbGeAlD
Simvastatin—ITGB2—hematopoietic system—sarcoma	0.00308	0.046	CbGeAlD
Simvastatin—ITGB2—connective tissue—sarcoma	0.00296	0.0443	CbGeAlD
Simvastatin—ITGB2—uterus—sarcoma	0.00233	0.0348	CbGeAlD
Simvastatin—ITGB2—lymphoid tissue—sarcoma	0.00217	0.0324	CbGeAlD
Simvastatin—ITGB2—tendon—sarcoma	0.00204	0.0305	CbGeAlD
Simvastatin—ITGB2—bone marrow—sarcoma	0.00197	0.0295	CbGeAlD
Simvastatin—ITGB2—Integrin cell surface interactions—COL18A1—sarcoma	0.00188	0.0507	CbGpPWpGaD
Simvastatin—SLCO1B1—mammary gland—sarcoma	0.00173	0.0258	CbGeAlD
Simvastatin—ITGB2—testis—sarcoma	0.00169	0.0252	CbGeAlD
Simvastatin—ITGB2—liver—sarcoma	0.0016	0.0238	CbGeAlD
Simvastatin—ITGB2—HIF-1-alpha transcription factor network—NPM1—sarcoma	0.00153	0.0411	CbGpPWpGaD
Simvastatin—ITGB2—Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell—CD34—sarcoma	0.00151	0.0407	CbGpPWpGaD
Simvastatin—ITGB2—Cell surface interactions at the vascular wall—TEK—sarcoma	0.00141	0.0378	CbGpPWpGaD
Simvastatin—UGT1A3—liver—sarcoma	0.00134	0.0201	CbGeAlD
Simvastatin—ITGB2—Cell surface interactions at the vascular wall—ANGPT2—sarcoma	0.00129	0.0346	CbGpPWpGaD
Simvastatin—HMGCR—myometrium—sarcoma	0.00128	0.0191	CbGeAlD
Simvastatin—UGT1A1—hematopoietic system—sarcoma	0.00127	0.0189	CbGeAlD
Simvastatin—ITGB2—lymph node—sarcoma	0.00122	0.0183	CbGeAlD
Simvastatin—HMGCR—seminal vesicle—sarcoma	0.00116	0.0173	CbGeAlD
Simvastatin—ITGB2—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—PDGFRB—sarcoma	0.00114	0.0307	CbGpPWpGaD
Simvastatin—HMGCR—hematopoietic system—sarcoma	0.0011	0.0164	CbGeAlD
Simvastatin—ITGB2—HIF-1-alpha transcription factor network—CXCR4—sarcoma	0.00108	0.029	CbGpPWpGaD
Simvastatin—HMGCR—connective tissue—sarcoma	0.00106	0.0158	CbGeAlD
Simvastatin—SLCO1B1—hematopoietic system—sarcoma	0.00105	0.0157	CbGeAlD
Simvastatin—CYP2C8—mammary gland—sarcoma	0.000983	0.0147	CbGeAlD
Simvastatin—HMGCR—smooth muscle tissue—sarcoma	0.000968	0.0145	CbGeAlD
Simvastatin—ITGB2—amb2 Integrin signaling—MMP2—sarcoma	0.000959	0.0258	CbGpPWpGaD
Simvastatin—HMGCR—skin of body—sarcoma	0.000956	0.0143	CbGeAlD
Simvastatin—CYP2C9—mammary gland—sarcoma	0.000873	0.013	CbGeAlD
Simvastatin—SLCO1A2—hematopoietic system—sarcoma	0.000857	0.0128	CbGeAlD
Simvastatin—HMGCR—cardiac atrium—sarcoma	0.000835	0.0125	CbGeAlD
Simvastatin—HMGCR—uterus—sarcoma	0.00083	0.0124	CbGeAlD
Simvastatin—UGT2B7—testis—sarcoma	0.000816	0.0122	CbGeAlD
Simvastatin—ITGB2—Cell surface interactions at the vascular wall—PLCG1—sarcoma	0.000811	0.0218	CbGpPWpGaD
Simvastatin—CYP3A7—liver—sarcoma	0.000796	0.0119	CbGeAlD
Simvastatin—HMGCR—lymphoid tissue—sarcoma	0.000774	0.0116	CbGeAlD
Simvastatin—UGT2B7—liver—sarcoma	0.000771	0.0115	CbGeAlD
Simvastatin—HMGCR—tendon—sarcoma	0.000728	0.0109	CbGeAlD
Simvastatin—HMGCR—bone marrow—sarcoma	0.000705	0.0105	CbGeAlD
Simvastatin—CYP2C19—hematopoietic system—sarcoma	0.000686	0.0103	CbGeAlD
Simvastatin—CYP3A7-CYP3A51P—liver—sarcoma	0.000676	0.0101	CbGeAlD
Simvastatin—ITGB2—Integrin cell surface interactions—KDR—sarcoma	0.000659	0.0177	CbGpPWpGaD
Simvastatin—UGT1A1—liver—sarcoma	0.000656	0.0098	CbGeAlD
Simvastatin—ITGB2—Toll Like Receptor 4 (TLR4) Cascade—ATF1—sarcoma	0.000652	0.0175	CbGpPWpGaD
Simvastatin—ITGB2—Extracellular matrix organization—COL18A1—sarcoma	0.000622	0.0167	CbGpPWpGaD
Simvastatin—ITGB2—Focal Adhesion—VEGFC—sarcoma	0.000613	0.0165	CbGpPWpGaD
Simvastatin—HMGCR—testis—sarcoma	0.000602	0.009	CbGeAlD
Simvastatin—CYP2C8—hematopoietic system—sarcoma	0.000599	0.00895	CbGeAlD
Simvastatin—ITGB2—Toll-Like Receptors Cascades—ATF1—sarcoma	0.000581	0.0156	CbGpPWpGaD
Simvastatin—ITGB2—HIF-1-alpha transcription factor network—CREB1—sarcoma	0.000578	0.0155	CbGpPWpGaD
Simvastatin—HMGCR—liver—sarcoma	0.00057	0.00851	CbGeAlD
Simvastatin—SLCO1B1—liver—sarcoma	0.000546	0.00815	CbGeAlD
Simvastatin—CYP3A5—hematopoietic system—sarcoma	0.00054	0.00808	CbGeAlD
Simvastatin—CYP2B6—hematopoietic system—sarcoma	0.000537	0.00803	CbGeAlD
Simvastatin—ITGB2—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SRC—sarcoma	0.000535	0.0144	CbGpPWpGaD
Simvastatin—CYP2C9—hematopoietic system—sarcoma	0.000532	0.00795	CbGeAlD
Simvastatin—UGT1A3—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.00053	0.0143	CbGpPWpGaD
Simvastatin—ABCC2—tendon—sarcoma	0.000528	0.0079	CbGeAlD
Simvastatin—ITGB2—Focal Adhesion—FLT1—sarcoma	0.00049	0.0132	CbGpPWpGaD
Simvastatin—SLCO1A2—testis—sarcoma	0.00047	0.00702	CbGeAlD
Simvastatin—ITGB2—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—sarcoma	0.000469	0.0126	CbGpPWpGaD
Simvastatin—CYP2B6—skin of body—sarcoma	0.000467	0.00698	CbGeAlD
Simvastatin—SLCO1A2—liver—sarcoma	0.000444	0.00664	CbGeAlD
Simvastatin—ABCC2—testis—sarcoma	0.000438	0.00654	CbGeAlD
Simvastatin—HMGCR—lymph node—sarcoma	0.000437	0.00653	CbGeAlD
Simvastatin—ITGB2—HIF-1-alpha transcription factor network—JUN—sarcoma	0.000415	0.0112	CbGpPWpGaD
Simvastatin—ABCC2—liver—sarcoma	0.000414	0.00618	CbGeAlD
Simvastatin—CYP3A4—hematopoietic system—sarcoma	0.000406	0.00606	CbGeAlD
Simvastatin—CYP2D6—hematopoietic system—sarcoma	0.000399	0.00596	CbGeAlD
Simvastatin—ITGB2—Hemostasis—TEK—sarcoma	0.000381	0.0103	CbGpPWpGaD
Simvastatin—CYP2B6—lymphoid tissue—sarcoma	0.000378	0.00565	CbGeAlD
Simvastatin—UGT1A1—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000366	0.00985	CbGpPWpGaD
Simvastatin—ITGB2—HIF-1-alpha transcription factor network—VEGFA—sarcoma	0.000363	0.00976	CbGpPWpGaD
Simvastatin—ITGB2—Focal Adhesion—IGF1R—sarcoma	0.000359	0.00966	CbGpPWpGaD
Simvastatin—ABCC2—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000357	0.00961	CbGpPWpGaD
Simvastatin—CYP2C19—liver—sarcoma	0.000355	0.00531	CbGeAlD
Simvastatin—ITGB2—Toll Like Receptor 4 (TLR4) Cascade—CREB1—sarcoma	0.000353	0.0095	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—ANGPT2—sarcoma	0.000349	0.00938	CbGpPWpGaD
Simvastatin—ITGB2—Focal Adhesion—PDGFRB—sarcoma	0.000341	0.00917	CbGpPWpGaD
Simvastatin—Hepatic function abnormal—Doxorubicin—sarcoma	0.00034	0.00274	CcSEcCtD
Simvastatin—Anaphylactic shock—Mitoxantrone—sarcoma	0.000339	0.00272	CcSEcCtD
Simvastatin—Oedema—Mitoxantrone—sarcoma	0.000339	0.00272	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Thiotepa—sarcoma	0.000339	0.00272	CcSEcCtD
Simvastatin—Photosensitivity—Doxorubicin—sarcoma	0.000339	0.00272	CcSEcCtD
Simvastatin—Decreased appetite—Dactinomycin—sarcoma	0.000338	0.00272	CcSEcCtD
Simvastatin—Fatigue—Thiotepa—sarcoma	0.000338	0.00272	CcSEcCtD
Simvastatin—Dysgeusia—Etoposide—sarcoma	0.000338	0.00272	CcSEcCtD
Simvastatin—Infection—Mitoxantrone—sarcoma	0.000337	0.00271	CcSEcCtD
Simvastatin—ITGB2—Focal Adhesion—PDGFRA—sarcoma	0.000336	0.00903	CbGpPWpGaD
Simvastatin—Fatigue—Dactinomycin—sarcoma	0.000336	0.0027	CcSEcCtD
Simvastatin—Pain—Thiotepa—sarcoma	0.000335	0.0027	CcSEcCtD
Simvastatin—Constipation—Thiotepa—sarcoma	0.000335	0.0027	CcSEcCtD
Simvastatin—ABCB1—myometrium—sarcoma	0.000334	0.005	CbGeAlD
Simvastatin—Purpura—Epirubicin—sarcoma	0.000333	0.00268	CcSEcCtD
Simvastatin—Pain—Dactinomycin—sarcoma	0.000333	0.00268	CcSEcCtD
Simvastatin—Vascular purpura—Doxorubicin—sarcoma	0.000332	0.00267	CcSEcCtD
Simvastatin—Muscle spasms—Etoposide—sarcoma	0.000332	0.00267	CcSEcCtD
Simvastatin—Thrombocytopenia—Mitoxantrone—sarcoma	0.000332	0.00267	CcSEcCtD
Simvastatin—Anorexia—Vincristine—sarcoma	0.000332	0.00267	CcSEcCtD
Simvastatin—Eczema—Doxorubicin—sarcoma	0.000331	0.00266	CcSEcCtD
Simvastatin—Hepatic failure—Doxorubicin—sarcoma	0.000331	0.00266	CcSEcCtD
Simvastatin—CYP2C8—testis—sarcoma	0.000328	0.0049	CbGeAlD
Simvastatin—Feeling abnormal—Thiotepa—sarcoma	0.000323	0.0026	CcSEcCtD
Simvastatin—Anorexia—Mitoxantrone—sarcoma	0.000323	0.0026	CcSEcCtD
Simvastatin—ABCB1—embryo—sarcoma	0.000322	0.00481	CbGeAlD
Simvastatin—Feeling abnormal—Dactinomycin—sarcoma	0.000321	0.00258	CcSEcCtD
Simvastatin—Gastrointestinal pain—Thiotepa—sarcoma	0.000321	0.00258	CcSEcCtD
Simvastatin—Ill-defined disorder—Etoposide—sarcoma	0.00032	0.00258	CcSEcCtD
Simvastatin—Anaemia—Etoposide—sarcoma	0.000319	0.00257	CcSEcCtD
Simvastatin—Gastrointestinal pain—Dactinomycin—sarcoma	0.000318	0.00256	CcSEcCtD
Simvastatin—ABCC2—lymph node—sarcoma	0.000317	0.00474	CbGeAlD
Simvastatin—Musculoskeletal discomfort—Vincristine—sarcoma	0.000317	0.00255	CcSEcCtD
Simvastatin—ITGB2—Toll-Like Receptors Cascades—CREB1—sarcoma	0.000315	0.00846	CbGpPWpGaD
Simvastatin—Insomnia—Vincristine—sarcoma	0.000315	0.00253	CcSEcCtD
Simvastatin—Paraesthesia—Vincristine—sarcoma	0.000312	0.00251	CcSEcCtD
Simvastatin—Urticaria—Thiotepa—sarcoma	0.000312	0.00251	CcSEcCtD
Simvastatin—Malaise—Etoposide—sarcoma	0.000311	0.0025	CcSEcCtD
Simvastatin—CYP2C8—liver—sarcoma	0.00031	0.00464	CbGeAlD
Simvastatin—Vertigo—Etoposide—sarcoma	0.00031	0.00249	CcSEcCtD
Simvastatin—Body temperature increased—Thiotepa—sarcoma	0.00031	0.00249	CcSEcCtD
Simvastatin—Abdominal pain—Thiotepa—sarcoma	0.00031	0.00249	CcSEcCtD
Simvastatin—Leukopenia—Etoposide—sarcoma	0.000309	0.00248	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000309	0.00248	CcSEcCtD
Simvastatin—Purpura—Doxorubicin—sarcoma	0.000308	0.00248	CcSEcCtD
Simvastatin—Body temperature increased—Dactinomycin—sarcoma	0.000308	0.00247	CcSEcCtD
Simvastatin—Abdominal pain—Dactinomycin—sarcoma	0.000308	0.00247	CcSEcCtD
Simvastatin—Paraesthesia—Mitoxantrone—sarcoma	0.000304	0.00245	CcSEcCtD
Simvastatin—Decreased appetite—Vincristine—sarcoma	0.000302	0.00243	CcSEcCtD
Simvastatin—ABCB1—seminal vesicle—sarcoma	0.000302	0.00451	CbGeAlD
Simvastatin—Dyspnoea—Mitoxantrone—sarcoma	0.000302	0.00243	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Vincristine—sarcoma	0.0003	0.00241	CcSEcCtD
Simvastatin—Fatigue—Vincristine—sarcoma	0.0003	0.00241	CcSEcCtD
Simvastatin—Dyspepsia—Mitoxantrone—sarcoma	0.000298	0.0024	CcSEcCtD
Simvastatin—Constipation—Vincristine—sarcoma	0.000297	0.00239	CcSEcCtD
Simvastatin—Pain—Vincristine—sarcoma	0.000297	0.00239	CcSEcCtD
Simvastatin—Decreased appetite—Mitoxantrone—sarcoma	0.000294	0.00237	CcSEcCtD
Simvastatin—CYP2B6—testis—sarcoma	0.000294	0.0044	CbGeAlD
Simvastatin—Chest pain—Etoposide—sarcoma	0.000294	0.00236	CcSEcCtD
Simvastatin—Fatigue—Mitoxantrone—sarcoma	0.000292	0.00235	CcSEcCtD
Simvastatin—Discomfort—Etoposide—sarcoma	0.00029	0.00234	CcSEcCtD
Simvastatin—Pain—Mitoxantrone—sarcoma	0.00029	0.00233	CcSEcCtD
Simvastatin—Constipation—Mitoxantrone—sarcoma	0.00029	0.00233	CcSEcCtD
Simvastatin—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.000289	0.00233	CcSEcCtD
Simvastatin—Hypersensitivity—Thiotepa—sarcoma	0.000289	0.00232	CcSEcCtD
Simvastatin—ABCB1—hematopoietic system—sarcoma	0.000287	0.00429	CbGeAlD
Simvastatin—Hypersensitivity—Dactinomycin—sarcoma	0.000287	0.00231	CcSEcCtD
Simvastatin—Gastrointestinal pain—Vincristine—sarcoma	0.000284	0.00229	CcSEcCtD
Simvastatin—Gastritis—Epirubicin—sarcoma	0.000284	0.00229	CcSEcCtD
Simvastatin—Confusional state—Etoposide—sarcoma	0.000284	0.00228	CcSEcCtD
Simvastatin—Muscular weakness—Epirubicin—sarcoma	0.000283	0.00228	CcSEcCtD
Simvastatin—ITGB2—Focal Adhesion—KDR—sarcoma	0.000283	0.0076	CbGpPWpGaD
Simvastatin—Anaphylactic shock—Etoposide—sarcoma	0.000282	0.00227	CcSEcCtD
Simvastatin—Asthenia—Thiotepa—sarcoma	0.000281	0.00226	CcSEcCtD
Simvastatin—CYP3A5—liver—sarcoma	0.00028	0.00418	CbGeAlD
Simvastatin—ITGB2—Hemostasis—VEGFC—sarcoma	0.00028	0.00753	CbGpPWpGaD
Simvastatin—Infection—Etoposide—sarcoma	0.00028	0.00225	CcSEcCtD
Simvastatin—Asthenia—Dactinomycin—sarcoma	0.000279	0.00225	CcSEcCtD
Simvastatin—Feeling abnormal—Mitoxantrone—sarcoma	0.000279	0.00224	CcSEcCtD
Simvastatin—CYP2B6—liver—sarcoma	0.000278	0.00416	CbGeAlD
Simvastatin—Pruritus—Thiotepa—sarcoma	0.000278	0.00223	CcSEcCtD
Simvastatin—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000277	0.00223	CcSEcCtD
Simvastatin—Thrombocytopenia—Etoposide—sarcoma	0.000276	0.00222	CcSEcCtD
Simvastatin—CYP2C9—liver—sarcoma	0.000276	0.00412	CbGeAlD
Simvastatin—Eosinophilia—Epirubicin—sarcoma	0.000275	0.00221	CcSEcCtD
Simvastatin—Abdominal pain—Vincristine—sarcoma	0.000275	0.00221	CcSEcCtD
Simvastatin—Body temperature increased—Vincristine—sarcoma	0.000275	0.00221	CcSEcCtD
Simvastatin—Pancreatitis—Epirubicin—sarcoma	0.000272	0.00219	CcSEcCtD
Simvastatin—ITGB2—Cell surface interactions at the vascular wall—SRC—sarcoma	0.000269	0.00724	CbGpPWpGaD
Simvastatin—Urticaria—Mitoxantrone—sarcoma	0.000269	0.00216	CcSEcCtD
Simvastatin—ITGB2—Adaptive Immune System—CD34—sarcoma	0.000269	0.00723	CbGpPWpGaD
Simvastatin—Anorexia—Etoposide—sarcoma	0.000269	0.00216	CcSEcCtD
Simvastatin—Diarrhoea—Thiotepa—sarcoma	0.000268	0.00216	CcSEcCtD
Simvastatin—Body temperature increased—Mitoxantrone—sarcoma	0.000268	0.00215	CcSEcCtD
Simvastatin—Abdominal pain—Mitoxantrone—sarcoma	0.000268	0.00215	CcSEcCtD
Simvastatin—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000268	0.00215	CcSEcCtD
Simvastatin—ITGB2—Integrin-mediated Cell Adhesion—SRC—sarcoma	0.000267	0.00719	CbGpPWpGaD
Simvastatin—Bronchitis—Epirubicin—sarcoma	0.000267	0.00215	CcSEcCtD
Simvastatin—Diarrhoea—Dactinomycin—sarcoma	0.000266	0.00214	CcSEcCtD
Simvastatin—Gastritis—Doxorubicin—sarcoma	0.000263	0.00212	CcSEcCtD
Simvastatin—Muscular weakness—Doxorubicin—sarcoma	0.000262	0.00211	CcSEcCtD
Simvastatin—Dizziness—Thiotepa—sarcoma	0.000259	0.00209	CcSEcCtD
Simvastatin—ITGB2—Cell surface interactions at the vascular wall—NRAS—sarcoma	0.000259	0.00697	CbGpPWpGaD
Simvastatin—Upper respiratory tract infection—Epirubicin—sarcoma	0.000258	0.00208	CcSEcCtD
Simvastatin—Hypersensitivity—Vincristine—sarcoma	0.000256	0.00206	CcSEcCtD
Simvastatin—HMGCR—SREBP signalling—CREB1—sarcoma	0.000255	0.00686	CbGpPWpGaD
Simvastatin—Eosinophilia—Doxorubicin—sarcoma	0.000254	0.00205	CcSEcCtD
Simvastatin—ITGB2—Toll Like Receptor 4 (TLR4) Cascade—JUN—sarcoma	0.000254	0.00683	CbGpPWpGaD
Simvastatin—Photosensitivity reaction—Epirubicin—sarcoma	0.000254	0.00204	CcSEcCtD
Simvastatin—Paraesthesia—Etoposide—sarcoma	0.000253	0.00203	CcSEcCtD
Simvastatin—Pancreatitis—Doxorubicin—sarcoma	0.000252	0.00203	CcSEcCtD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—ATF1—sarcoma	0.000252	0.00677	CbGpPWpGaD
Simvastatin—Dyspnoea—Etoposide—sarcoma	0.000251	0.00202	CcSEcCtD
Simvastatin—Hypersensitivity—Mitoxantrone—sarcoma	0.00025	0.00201	CcSEcCtD
Simvastatin—Asthenia—Vincristine—sarcoma	0.00025	0.00201	CcSEcCtD
Simvastatin—Vomiting—Thiotepa—sarcoma	0.000249	0.00201	CcSEcCtD
Simvastatin—Vomiting—Dactinomycin—sarcoma	0.000248	0.00199	CcSEcCtD
Simvastatin—Rash—Thiotepa—sarcoma	0.000247	0.00199	CcSEcCtD
Simvastatin—Bronchitis—Doxorubicin—sarcoma	0.000247	0.00199	CcSEcCtD
Simvastatin—Dermatitis—Thiotepa—sarcoma	0.000247	0.00199	CcSEcCtD
Simvastatin—Headache—Thiotepa—sarcoma	0.000246	0.00198	CcSEcCtD
Simvastatin—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000246	0.00197	CcSEcCtD
Simvastatin—Rash—Dactinomycin—sarcoma	0.000245	0.00197	CcSEcCtD
Simvastatin—Decreased appetite—Etoposide—sarcoma	0.000245	0.00197	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Etoposide—sarcoma	0.000243	0.00196	CcSEcCtD
Simvastatin—Asthenia—Mitoxantrone—sarcoma	0.000243	0.00195	CcSEcCtD
Simvastatin—Fatigue—Etoposide—sarcoma	0.000243	0.00195	CcSEcCtD
Simvastatin—Neuropathy peripheral—Epirubicin—sarcoma	0.000243	0.00195	CcSEcCtD
Simvastatin—Jaundice—Epirubicin—sarcoma	0.000241	0.00194	CcSEcCtD
Simvastatin—Constipation—Etoposide—sarcoma	0.000241	0.00194	CcSEcCtD
Simvastatin—Pain—Etoposide—sarcoma	0.000241	0.00194	CcSEcCtD
Simvastatin—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000239	0.00192	CcSEcCtD
Simvastatin—Diarrhoea—Vincristine—sarcoma	0.000238	0.00191	CcSEcCtD
Simvastatin—Photosensitivity reaction—Doxorubicin—sarcoma	0.000235	0.00189	CcSEcCtD
Simvastatin—Nausea—Thiotepa—sarcoma	0.000233	0.00187	CcSEcCtD
Simvastatin—Sinusitis—Epirubicin—sarcoma	0.000232	0.00187	CcSEcCtD
Simvastatin—Feeling abnormal—Etoposide—sarcoma	0.000232	0.00187	CcSEcCtD
Simvastatin—Diarrhoea—Mitoxantrone—sarcoma	0.000232	0.00186	CcSEcCtD
Simvastatin—Nausea—Dactinomycin—sarcoma	0.000231	0.00186	CcSEcCtD
Simvastatin—Gastrointestinal pain—Etoposide—sarcoma	0.00023	0.00185	CcSEcCtD
Simvastatin—Dizziness—Vincristine—sarcoma	0.00023	0.00185	CcSEcCtD
Simvastatin—CYP2B6—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000228	0.00613	CbGpPWpGaD
Simvastatin—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000227	0.00183	CcSEcCtD
Simvastatin—ITGB2—Toll-Like Receptors Cascades—JUN—sarcoma	0.000226	0.00609	CbGpPWpGaD
Simvastatin—Neuropathy peripheral—Doxorubicin—sarcoma	0.000225	0.00181	CcSEcCtD
Simvastatin—Urticaria—Etoposide—sarcoma	0.000224	0.0018	CcSEcCtD
Simvastatin—Jaundice—Doxorubicin—sarcoma	0.000223	0.0018	CcSEcCtD
Simvastatin—ITGB2—Cell surface interactions at the vascular wall—KRAS—sarcoma	0.000223	0.006	CbGpPWpGaD
Simvastatin—Body temperature increased—Etoposide—sarcoma	0.000223	0.00179	CcSEcCtD
Simvastatin—Abdominal pain—Etoposide—sarcoma	0.000223	0.00179	CcSEcCtD
Simvastatin—CYP3A5—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000223	0.00599	CbGpPWpGaD
Simvastatin—Hepatitis—Epirubicin—sarcoma	0.000222	0.00179	CcSEcCtD
Simvastatin—Vomiting—Vincristine—sarcoma	0.000221	0.00178	CcSEcCtD
Simvastatin—ITGB2—Hemostasis—PLCG1—sarcoma	0.00022	0.00592	CbGpPWpGaD
Simvastatin—Rash—Vincristine—sarcoma	0.000219	0.00176	CcSEcCtD
Simvastatin—Dermatitis—Vincristine—sarcoma	0.000219	0.00176	CcSEcCtD
Simvastatin—CYP2D6—testis—sarcoma	0.000219	0.00327	CbGeAlD
Simvastatin—Headache—Vincristine—sarcoma	0.000218	0.00175	CcSEcCtD
Simvastatin—ITGB2—Extracellular matrix organization—KDR—sarcoma	0.000217	0.00584	CbGpPWpGaD
Simvastatin—ABCB1—uterus—sarcoma	0.000217	0.00324	CbGeAlD
Simvastatin—Vomiting—Mitoxantrone—sarcoma	0.000215	0.00173	CcSEcCtD
Simvastatin—Sinusitis—Doxorubicin—sarcoma	0.000215	0.00173	CcSEcCtD
Simvastatin—Rash—Mitoxantrone—sarcoma	0.000214	0.00172	CcSEcCtD
Simvastatin—Dermatitis—Mitoxantrone—sarcoma	0.000213	0.00172	CcSEcCtD
Simvastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL2—sarcoma	0.000213	0.00572	CbGpPWpGaD
Simvastatin—Headache—Mitoxantrone—sarcoma	0.000212	0.00171	CcSEcCtD
Simvastatin—Erythema multiforme—Epirubicin—sarcoma	0.00021	0.00169	CcSEcCtD
Simvastatin—CYP3A4—liver—sarcoma	0.00021	0.00314	CbGeAlD
Simvastatin—Hypersensitivity—Etoposide—sarcoma	0.000208	0.00167	CcSEcCtD
Simvastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	0.000207	0.00556	CbGpPWpGaD
Simvastatin—CYP2D6—liver—sarcoma	0.000207	0.00309	CbGeAlD
Simvastatin—Nausea—Vincristine—sarcoma	0.000207	0.00166	CcSEcCtD
Simvastatin—Flushing—Epirubicin—sarcoma	0.000206	0.00166	CcSEcCtD
Simvastatin—Hepatitis—Doxorubicin—sarcoma	0.000206	0.00165	CcSEcCtD
Simvastatin—Asthenia—Etoposide—sarcoma	0.000202	0.00163	CcSEcCtD
Simvastatin—ABCB1—lymphoid tissue—sarcoma	0.000202	0.00302	CbGeAlD
Simvastatin—Nausea—Mitoxantrone—sarcoma	0.000201	0.00162	CcSEcCtD
Simvastatin—Chills—Epirubicin—sarcoma	0.000199	0.0016	CcSEcCtD
Simvastatin—Pruritus—Etoposide—sarcoma	0.000199	0.0016	CcSEcCtD
Simvastatin—ITGB2—Innate Immune System—PLCG1—sarcoma	0.000198	0.00533	CbGpPWpGaD
Simvastatin—Alopecia—Epirubicin—sarcoma	0.000196	0.00158	CcSEcCtD
Simvastatin—Mental disorder—Epirubicin—sarcoma	0.000195	0.00157	CcSEcCtD
Simvastatin—Erythema multiforme—Doxorubicin—sarcoma	0.000194	0.00156	CcSEcCtD
Simvastatin—ITGB2—Adaptive Immune System—PTPRC—sarcoma	0.000194	0.00523	CbGpPWpGaD
Simvastatin—Erythema—Epirubicin—sarcoma	0.000194	0.00156	CcSEcCtD
Simvastatin—Diarrhoea—Etoposide—sarcoma	0.000193	0.00155	CcSEcCtD
Simvastatin—Flushing—Doxorubicin—sarcoma	0.000191	0.00154	CcSEcCtD
Simvastatin—Flatulence—Epirubicin—sarcoma	0.000191	0.00153	CcSEcCtD
Simvastatin—ITGB2—Adaptive Immune System—PLCG1—sarcoma	0.00019	0.00511	CbGpPWpGaD
Simvastatin—ITGB2—Cell surface interactions at the vascular wall—HRAS—sarcoma	0.00019	0.0051	CbGpPWpGaD
Simvastatin—Dysgeusia—Epirubicin—sarcoma	0.00019	0.00152	CcSEcCtD
Simvastatin—ITGB2—Innate Immune System—ATF1—sarcoma	0.000188	0.00506	CbGpPWpGaD
Simvastatin—ITGB2—Integrin-mediated Cell Adhesion—HRAS—sarcoma	0.000188	0.00506	CbGpPWpGaD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—FOXO1—sarcoma	0.000188	0.00505	CbGpPWpGaD
Simvastatin—Dizziness—Etoposide—sarcoma	0.000186	0.0015	CcSEcCtD
Simvastatin—CYP2C19—Melatonin metabolism and effects—FOXO1—sarcoma	0.000186	0.00501	CbGpPWpGaD
Simvastatin—Muscle spasms—Epirubicin—sarcoma	0.000186	0.0015	CcSEcCtD
Simvastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	0.000186	0.00499	CbGpPWpGaD
Simvastatin—Chills—Doxorubicin—sarcoma	0.000185	0.00148	CcSEcCtD
Simvastatin—ABCB1—bone marrow—sarcoma	0.000184	0.00275	CbGeAlD
Simvastatin—Vision blurred—Epirubicin—sarcoma	0.000182	0.00147	CcSEcCtD
Simvastatin—Alopecia—Doxorubicin—sarcoma	0.000182	0.00146	CcSEcCtD
Simvastatin—ABCB1—HIF-1-alpha transcription factor network—NPM1—sarcoma	0.000181	0.00486	CbGpPWpGaD
Simvastatin—Mental disorder—Doxorubicin—sarcoma	0.00018	0.00145	CcSEcCtD
Simvastatin—Ill-defined disorder—Epirubicin—sarcoma	0.00018	0.00144	CcSEcCtD
Simvastatin—Vomiting—Etoposide—sarcoma	0.000179	0.00144	CcSEcCtD
Simvastatin—Erythema—Doxorubicin—sarcoma	0.000179	0.00144	CcSEcCtD
Simvastatin—Anaemia—Epirubicin—sarcoma	0.000179	0.00144	CcSEcCtD
Simvastatin—ITGB2—Focal Adhesion—CCND1—sarcoma	0.000179	0.0048	CbGpPWpGaD
Simvastatin—ITGB2—Focal Adhesion—JUN—sarcoma	0.000178	0.00479	CbGpPWpGaD
Simvastatin—Rash—Etoposide—sarcoma	0.000178	0.00143	CcSEcCtD
Simvastatin—Dermatitis—Etoposide—sarcoma	0.000177	0.00143	CcSEcCtD
Simvastatin—ITGB2—Extracellular matrix organization—MMP2—sarcoma	0.000177	0.00477	CbGpPWpGaD
Simvastatin—ITGB2—Focal Adhesion—CTNNB1—sarcoma	0.000177	0.00476	CbGpPWpGaD
Simvastatin—Headache—Etoposide—sarcoma	0.000177	0.00142	CcSEcCtD
Simvastatin—Flatulence—Doxorubicin—sarcoma	0.000176	0.00142	CcSEcCtD
Simvastatin—Dysgeusia—Doxorubicin—sarcoma	0.000175	0.00141	CcSEcCtD
Simvastatin—Malaise—Epirubicin—sarcoma	0.000175	0.0014	CcSEcCtD
Simvastatin—Vertigo—Epirubicin—sarcoma	0.000174	0.0014	CcSEcCtD
Simvastatin—Leukopenia—Epirubicin—sarcoma	0.000173	0.00139	CcSEcCtD
Simvastatin—Muscle spasms—Doxorubicin—sarcoma	0.000172	0.00138	CcSEcCtD
Simvastatin—CYP2C19—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000172	0.00463	CbGpPWpGaD
Simvastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—sarcoma	0.000171	0.00461	CbGpPWpGaD
Simvastatin—CYP2D6—Melatonin metabolism and effects—FOXO1—sarcoma	0.000171	0.00461	CbGpPWpGaD
Simvastatin—Vision blurred—Doxorubicin—sarcoma	0.000169	0.00136	CcSEcCtD
Simvastatin—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000168	0.00452	CbGpPWpGaD
Simvastatin—Nausea—Etoposide—sarcoma	0.000167	0.00135	CcSEcCtD
Simvastatin—Ill-defined disorder—Doxorubicin—sarcoma	0.000166	0.00134	CcSEcCtD
Simvastatin—Anaemia—Doxorubicin—sarcoma	0.000166	0.00133	CcSEcCtD
Simvastatin—Chest pain—Epirubicin—sarcoma	0.000165	0.00132	CcSEcCtD
Simvastatin—Myalgia—Epirubicin—sarcoma	0.000165	0.00132	CcSEcCtD
Simvastatin—Arthralgia—Epirubicin—sarcoma	0.000165	0.00132	CcSEcCtD
Simvastatin—Anxiety—Epirubicin—sarcoma	0.000164	0.00132	CcSEcCtD
Simvastatin—ITGB2—Immune System—CD34—sarcoma	0.000163	0.00438	CbGpPWpGaD
Simvastatin—Discomfort—Epirubicin—sarcoma	0.000163	0.00131	CcSEcCtD
Simvastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	0.000163	0.00437	CbGpPWpGaD
Simvastatin—Malaise—Doxorubicin—sarcoma	0.000161	0.0013	CcSEcCtD
Simvastatin—Vertigo—Doxorubicin—sarcoma	0.000161	0.00129	CcSEcCtD
Simvastatin—Leukopenia—Doxorubicin—sarcoma	0.00016	0.00129	CcSEcCtD
Simvastatin—ITGB2—Focal Adhesion—SRC—sarcoma	0.00016	0.0043	CbGpPWpGaD
Simvastatin—Confusional state—Epirubicin—sarcoma	0.000159	0.00128	CcSEcCtD
Simvastatin—Oedema—Epirubicin—sarcoma	0.000158	0.00127	CcSEcCtD
Simvastatin—Anaphylactic shock—Epirubicin—sarcoma	0.000158	0.00127	CcSEcCtD
Simvastatin—ABCB1—testis—sarcoma	0.000157	0.00235	CbGeAlD
Simvastatin—CYP2C9—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000157	0.00422	CbGpPWpGaD
Simvastatin—Infection—Epirubicin—sarcoma	0.000157	0.00126	CcSEcCtD
Simvastatin—ITGB2—Focal Adhesion—VEGFA—sarcoma	0.000156	0.00419	CbGpPWpGaD
Simvastatin—Thrombocytopenia—Epirubicin—sarcoma	0.000155	0.00124	CcSEcCtD
Simvastatin—Myalgia—Doxorubicin—sarcoma	0.000152	0.00123	CcSEcCtD
Simvastatin—Chest pain—Doxorubicin—sarcoma	0.000152	0.00123	CcSEcCtD
Simvastatin—Arthralgia—Doxorubicin—sarcoma	0.000152	0.00123	CcSEcCtD
Simvastatin—Anxiety—Doxorubicin—sarcoma	0.000152	0.00122	CcSEcCtD
Simvastatin—Discomfort—Doxorubicin—sarcoma	0.000151	0.00121	CcSEcCtD
Simvastatin—Anorexia—Epirubicin—sarcoma	0.000151	0.00121	CcSEcCtD
Simvastatin—ABCB1—liver—sarcoma	0.000149	0.00222	CbGeAlD
Simvastatin—Confusional state—Doxorubicin—sarcoma	0.000147	0.00118	CcSEcCtD
Simvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—sarcoma	0.000147	0.00395	CbGpPWpGaD
Simvastatin—Anaphylactic shock—Doxorubicin—sarcoma	0.000146	0.00118	CcSEcCtD
Simvastatin—Oedema—Doxorubicin—sarcoma	0.000146	0.00118	CcSEcCtD
Simvastatin—Infection—Doxorubicin—sarcoma	0.000145	0.00117	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000144	0.00116	CcSEcCtD
Simvastatin—Thrombocytopenia—Doxorubicin—sarcoma	0.000143	0.00115	CcSEcCtD
Simvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	0.000143	0.00384	CbGpPWpGaD
Simvastatin—Insomnia—Epirubicin—sarcoma	0.000143	0.00115	CcSEcCtD
Simvastatin—Paraesthesia—Epirubicin—sarcoma	0.000142	0.00114	CcSEcCtD
Simvastatin—Dyspnoea—Epirubicin—sarcoma	0.000141	0.00113	CcSEcCtD
Simvastatin—ITGB2—Innate Immune System—FOXO1—sarcoma	0.000141	0.00378	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—PDGFRB—sarcoma	0.00014	0.00377	CbGpPWpGaD
Simvastatin—ITGB2—Focal Adhesion—EGFR—sarcoma	0.00014	0.00377	CbGpPWpGaD
Simvastatin—Anorexia—Doxorubicin—sarcoma	0.000139	0.00112	CcSEcCtD
Simvastatin—Dyspepsia—Epirubicin—sarcoma	0.000139	0.00112	CcSEcCtD
Simvastatin—ITGB2—Innate Immune System—PDGFRA—sarcoma	0.000138	0.00371	CbGpPWpGaD
Simvastatin—Decreased appetite—Epirubicin—sarcoma	0.000137	0.0011	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Epirubicin—sarcoma	0.000136	0.0011	CcSEcCtD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—CREB1—sarcoma	0.000136	0.00367	CbGpPWpGaD
Simvastatin—Fatigue—Epirubicin—sarcoma	0.000136	0.00109	CcSEcCtD
Simvastatin—Constipation—Epirubicin—sarcoma	0.000135	0.00109	CcSEcCtD
Simvastatin—Pain—Epirubicin—sarcoma	0.000135	0.00109	CcSEcCtD
Simvastatin—ITGB2—Adaptive Immune System—FOXO1—sarcoma	0.000135	0.00363	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—PDGFRB—sarcoma	0.000135	0.00362	CbGpPWpGaD
Simvastatin—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000133	0.00107	CcSEcCtD
Simvastatin—ITGB2—Adaptive Immune System—PDGFRA—sarcoma	0.000133	0.00357	CbGpPWpGaD
Simvastatin—Insomnia—Doxorubicin—sarcoma	0.000132	0.00106	CcSEcCtD
Simvastatin—Paraesthesia—Doxorubicin—sarcoma	0.000131	0.00106	CcSEcCtD
Simvastatin—Dyspnoea—Doxorubicin—sarcoma	0.00013	0.00105	CcSEcCtD
Simvastatin—Feeling abnormal—Epirubicin—sarcoma	0.00013	0.00105	CcSEcCtD
Simvastatin—Gastrointestinal pain—Epirubicin—sarcoma	0.000129	0.00104	CcSEcCtD
Simvastatin—Dyspepsia—Doxorubicin—sarcoma	0.000129	0.00103	CcSEcCtD
Simvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	0.000128	0.00345	CbGpPWpGaD
Simvastatin—ABCB1—HIF-1-alpha transcription factor network—CXCR4—sarcoma	0.000127	0.00343	CbGpPWpGaD
Simvastatin—Decreased appetite—Doxorubicin—sarcoma	0.000127	0.00102	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000126	0.00101	CcSEcCtD
Simvastatin—Fatigue—Doxorubicin—sarcoma	0.000126	0.00101	CcSEcCtD
Simvastatin—Urticaria—Epirubicin—sarcoma	0.000125	0.00101	CcSEcCtD
Simvastatin—Constipation—Doxorubicin—sarcoma	0.000125	0.001	CcSEcCtD
Simvastatin—Pain—Doxorubicin—sarcoma	0.000125	0.001	CcSEcCtD
Simvastatin—Abdominal pain—Epirubicin—sarcoma	0.000125	0.001	CcSEcCtD
Simvastatin—Body temperature increased—Epirubicin—sarcoma	0.000125	0.001	CcSEcCtD
Simvastatin—HMGCR—AMPK Signaling—TP53—sarcoma	0.000121	0.00326	CbGpPWpGaD
Simvastatin—Feeling abnormal—Doxorubicin—sarcoma	0.00012	0.000968	CcSEcCtD
Simvastatin—Gastrointestinal pain—Doxorubicin—sarcoma	0.00012	0.000961	CcSEcCtD
Simvastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—sarcoma	0.000119	0.00321	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—PTPRC—sarcoma	0.000118	0.00317	CbGpPWpGaD
Simvastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—sarcoma	0.000117	0.00316	CbGpPWpGaD
Simvastatin—Hypersensitivity—Epirubicin—sarcoma	0.000116	0.000936	CcSEcCtD
Simvastatin—Urticaria—Doxorubicin—sarcoma	0.000116	0.000934	CcSEcCtD
Simvastatin—Abdominal pain—Doxorubicin—sarcoma	0.000116	0.000929	CcSEcCtD
Simvastatin—Body temperature increased—Doxorubicin—sarcoma	0.000116	0.000929	CcSEcCtD
Simvastatin—ITGB2—Immune System—PLCG1—sarcoma	0.000115	0.0031	CbGpPWpGaD
Simvastatin—ABCB1—lymph node—sarcoma	0.000114	0.0017	CbGeAlD
Simvastatin—Asthenia—Epirubicin—sarcoma	0.000113	0.000911	CcSEcCtD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—MDM2—sarcoma	0.000113	0.00303	CbGpPWpGaD
Simvastatin—ITGB2—Focal Adhesion—HRAS—sarcoma	0.000113	0.00303	CbGpPWpGaD
Simvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	0.000112	0.00302	CbGpPWpGaD
Simvastatin—Pruritus—Epirubicin—sarcoma	0.000112	0.000899	CcSEcCtD
Simvastatin—ITGB2—Immune System—ATF1—sarcoma	0.00011	0.00295	CbGpPWpGaD
Simvastatin—Diarrhoea—Epirubicin—sarcoma	0.000108	0.000869	CcSEcCtD
Simvastatin—Hypersensitivity—Doxorubicin—sarcoma	0.000108	0.000866	CcSEcCtD
Simvastatin—ITGB2—Innate Immune System—KIT—sarcoma	0.000107	0.00288	CbGpPWpGaD
Simvastatin—Asthenia—Doxorubicin—sarcoma	0.000105	0.000843	CcSEcCtD
Simvastatin—Dizziness—Epirubicin—sarcoma	0.000104	0.00084	CcSEcCtD
Simvastatin—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000104	0.00278	CbGpPWpGaD
Simvastatin—Pruritus—Doxorubicin—sarcoma	0.000103	0.000831	CcSEcCtD
Simvastatin—ITGB2—Adaptive Immune System—KIT—sarcoma	0.000103	0.00277	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—CREB1—sarcoma	0.000102	0.00274	CbGpPWpGaD
Simvastatin—Vomiting—Epirubicin—sarcoma	0.0001	0.000808	CcSEcCtD
Simvastatin—Diarrhoea—Doxorubicin—sarcoma	0.0001	0.000804	CcSEcCtD
Simvastatin—Rash—Epirubicin—sarcoma	9.96e-05	0.000801	CcSEcCtD
Simvastatin—Dermatitis—Epirubicin—sarcoma	9.95e-05	0.0008	CcSEcCtD
Simvastatin—Headache—Epirubicin—sarcoma	9.89e-05	0.000796	CcSEcCtD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—CCND1—sarcoma	9.82e-05	0.00264	CbGpPWpGaD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—JUN—sarcoma	9.8e-05	0.00264	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—CREB1—sarcoma	9.79e-05	0.00263	CbGpPWpGaD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—CTNNB1—sarcoma	9.73e-05	0.00262	CbGpPWpGaD
Simvastatin—Dizziness—Doxorubicin—sarcoma	9.66e-05	0.000777	CcSEcCtD
Simvastatin—Nausea—Epirubicin—sarcoma	9.38e-05	0.000754	CcSEcCtD
Simvastatin—Vomiting—Doxorubicin—sarcoma	9.29e-05	0.000747	CcSEcCtD
Simvastatin—Rash—Doxorubicin—sarcoma	9.21e-05	0.000741	CcSEcCtD
Simvastatin—Dermatitis—Doxorubicin—sarcoma	9.21e-05	0.00074	CcSEcCtD
Simvastatin—Headache—Doxorubicin—sarcoma	9.16e-05	0.000736	CcSEcCtD
Simvastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—sarcoma	9.1e-05	0.00245	CbGpPWpGaD
Simvastatin—Nausea—Doxorubicin—sarcoma	8.68e-05	0.000698	CcSEcCtD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—VEGFA—sarcoma	8.56e-05	0.0023	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—MDM2—sarcoma	8.43e-05	0.00227	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—IL2—sarcoma	8.37e-05	0.00225	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—FOXO1—sarcoma	8.19e-05	0.0022	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—PDGFRB—sarcoma	8.17e-05	0.0022	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—MDM2—sarcoma	8.1e-05	0.00218	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—PDGFRA—sarcoma	8.04e-05	0.00216	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—PDGFRA—sarcoma	8.01e-05	0.00216	CbGpPWpGaD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—MYC—sarcoma	7.88e-05	0.00212	CbGpPWpGaD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—EGFR—sarcoma	7.71e-05	0.00207	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	7.45e-05	0.002	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—JUN—sarcoma	7.33e-05	0.00197	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—SRC—sarcoma	7.3e-05	0.00196	CbGpPWpGaD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—KRAS—sarcoma	7.28e-05	0.00196	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—CTNNB1—sarcoma	7.27e-05	0.00196	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—VEGFA—sarcoma	7.11e-05	0.00191	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—NRAS—sarcoma	7.03e-05	0.00189	CbGpPWpGaD
Simvastatin—ABCB1—HIF-1-alpha transcription factor network—CREB1—sarcoma	6.83e-05	0.00184	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—SRC—sarcoma	6.58e-05	0.00177	CbGpPWpGaD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—sarcoma	6.47e-05	0.00174	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—NRAS—sarcoma	6.33e-05	0.0017	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—SRC—sarcoma	6.31e-05	0.0017	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—KIT—sarcoma	6.24e-05	0.00168	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—NRAS—sarcoma	6.07e-05	0.00163	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—KRAS—sarcoma	6.05e-05	0.00163	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—CREB1—sarcoma	5.94e-05	0.0016	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—EGFR—sarcoma	5.76e-05	0.00155	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—EGFR—sarcoma	5.53e-05	0.00149	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—KRAS—sarcoma	5.44e-05	0.00146	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—TP53—sarcoma	5.37e-05	0.00145	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—KRAS—sarcoma	5.23e-05	0.00141	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—HRAS—sarcoma	5.14e-05	0.00138	CbGpPWpGaD
Simvastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	5.01e-05	0.00135	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—MDM2—sarcoma	4.91e-05	0.00132	CbGpPWpGaD
Simvastatin—ABCB1—HIF-1-alpha transcription factor network—JUN—sarcoma	4.91e-05	0.00132	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—ENO2—sarcoma	4.81e-05	0.00129	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—HBA1—sarcoma	4.78e-05	0.00129	CbGpPWpGaD
Simvastatin—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	4.65e-05	0.00125	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—HRAS—sarcoma	4.63e-05	0.00124	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—HRAS—sarcoma	4.44e-05	0.0012	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—IL2—sarcoma	4.39e-05	0.00118	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—IL2—sarcoma	4.37e-05	0.00118	CbGpPWpGaD
Simvastatin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—sarcoma	4.29e-05	0.00115	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—JUN—sarcoma	4.27e-05	0.00115	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—CTNNB1—sarcoma	4.24e-05	0.00114	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—PLCG1—sarcoma	4.08e-05	0.0011	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	3.95e-05	0.00106	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—ENO2—sarcoma	3.92e-05	0.00105	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—HBA1—sarcoma	3.9e-05	0.00105	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—SRC—sarcoma	3.83e-05	0.00103	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—VEGFA—sarcoma	3.72e-05	0.000999	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—NRAS—sarcoma	3.68e-05	0.000991	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—EGFR—sarcoma	3.36e-05	0.000903	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—ENO2—sarcoma	3.33e-05	0.000897	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—PLCG1—sarcoma	3.33e-05	0.000895	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—HBA1—sarcoma	3.31e-05	0.000891	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—KRAS—sarcoma	3.17e-05	0.000853	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	2.92e-05	0.000785	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—ENO2—sarcoma	2.9e-05	0.000781	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—HBA1—sarcoma	2.89e-05	0.000776	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—PLCG1—sarcoma	2.83e-05	0.000761	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—ENO2—sarcoma	2.71e-05	0.000729	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—HRAS—sarcoma	2.7e-05	0.000725	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—HBA1—sarcoma	2.69e-05	0.000724	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—ENO2—sarcoma	2.48e-05	0.000668	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—HBA1—sarcoma	2.47e-05	0.000664	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PLCG1—sarcoma	2.46e-05	0.000663	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	2.41e-05	0.000649	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PLCG1—sarcoma	2.3e-05	0.000618	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—ENO2—sarcoma	2.28e-05	0.000613	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—HBA1—sarcoma	2.26e-05	0.000609	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PLCG1—sarcoma	2.11e-05	0.000567	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	2.1e-05	0.000566	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	2.1e-05	0.000564	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	2.08e-05	0.00056	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PLCG1—sarcoma	1.93e-05	0.00052	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	1.88e-05	0.000506	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	1.83e-05	0.000493	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	1.69e-05	0.000454	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—ENO2—sarcoma	1.69e-05	0.000453	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—HBA1—sarcoma	1.67e-05	0.00045	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	1.65e-05	0.000444	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—ENO2—sarcoma	1.65e-05	0.000443	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—HBA1—sarcoma	1.64e-05	0.00044	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	1.56e-05	0.000419	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PLCG1—sarcoma	1.43e-05	0.000385	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—ENO2—sarcoma	1.43e-05	0.000384	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—HBA1—sarcoma	1.42e-05	0.000381	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PLCG1—sarcoma	1.4e-05	0.000376	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	1.39e-05	0.000373	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—ENO2—sarcoma	1.27e-05	0.000342	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—HBA1—sarcoma	1.27e-05	0.00034	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—ENO2—sarcoma	1.24e-05	0.000334	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—HBA1—sarcoma	1.24e-05	0.000332	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PLCG1—sarcoma	1.21e-05	0.000326	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—ENO2—sarcoma	1.17e-05	0.000315	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—HBA1—sarcoma	1.16e-05	0.000313	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—ENO2—sarcoma	1.16e-05	0.000312	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—HBA1—sarcoma	1.15e-05	0.00031	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PLCG1—sarcoma	1.08e-05	0.000291	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PLCG1—sarcoma	1.05e-05	0.000284	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PLCG1—sarcoma	9.94e-06	0.000267	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PLCG1—sarcoma	9.85e-06	0.000265	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—ENO2—sarcoma	7.66e-06	0.000206	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—HBA1—sarcoma	7.61e-06	0.000205	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PLCG1—sarcoma	6.5e-06	0.000175	CbGpPWpGaD
